Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_2
1
17%
Ph not_applicable
3
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

completed467%
unknown117%
withdrawn117%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

The Role of Altered Nutrient Partitioning in Food Reward

NCT05200845
unknownnot_applicable

Analyzing the Brain Alterations of Acupuncture on Patients With CP/CPPS Evaluated by fMRI

NCT05075551
completed

Study of Cognition and Control in Youths

NCT03393390
completedphase_2

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

NCT00711477
completednot_applicable

fMRI and Ghlrein in Obesity and Binge Eating Disorder

NCT02038712
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05200845Not Applicable

The Role of Altered Nutrient Partitioning in Food Reward

Completed
NCT05075551Not Applicable

Analyzing the Brain Alterations of Acupuncture on Patients With CP/CPPS Evaluated by fMRI

Unknown
NCT03393390

Study of Cognition and Control in Youths

Completed
NCT00711477Phase 2

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

Completed
NCT02038712Not Applicable

fMRI and Ghlrein in Obesity and Binge Eating Disorder

Completed
NCT00715065

fMRI in Blood Phobia Syncope

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6